Product Code: GVR-4-68038-024-8
Pelvic Floor Electric Stimulator Market Growth & Trends
The global pelvic floor electric stimulator market size is anticipated to reach USD 539.38 million by 2030, registering a CAGR of 11.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of Urinary Incontinence (UI), rising investment in research and development by key players, and the growing number of awareness initiatives are anticipated to boost the market growth. Increasing cases of chronic diseases and UI are primary factors that are expected to drive market growth. According to the NHS, around 61% of the male population is suffering from lower urinary tract infections and around 34% of women are living with some type of UI. This disorder costs around USD 301.40 million per year to the NHS. Thereby, contributing to market growth.
Moreover, the geriatric population is at a higher risk for developing various neurological conditions, such as stroke, prostate cancer, and Alzheimer's, which may affect the lower urinary tract. This factor is anticipated to be one of the high growth rendering drivers of this market. As per the WHO, the global population of people aged 65 years and above is expected to rise from 7.00% in 2000 to 16.00% in 2050. This is expected to drive the market at a global level.Furthermore, the launch of technologically advanced products with comparatively lower prices is expected to drive market growth. For instance, in February 2020, Atlantic Therapeutics received U.S. FDA, clearance for the over-the-counter device INNOVO-a wearable and non-invasive pelvic floor muscle stimulator for treating stress urinary incontinence.
Pelvic Floor Electric Stimulator Market Report Highlights
- Based on the applications, the urinary incontinence segment dominated the market in 2022 with a share of 84.9% owing to the high number of patients suffering from UI globally
- North America dominated the market with the highest revenue share of 38.9% in 2022 owing to the rising incidence of targeted diseases, such as bladder obstruction, UI, and Benign Prostatic Hyperplasia (BPH)
- Moreover, this region is one of the most advanced regions globally with innovative technologies & infrastructure, resulting in significant healthcare facilities and patient care
- However, Asia Pacific is expected to lead the market from 2023 to 2030. The rising risk of Urinary Tract Infection (UTI) in women with increasing age, vaginal deliveries, and surgeries are driving the market growth in this region
Table of Content
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 By Application
- 1.1.2 Regional Scope
- 1.1.3 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.2 Volume Price Analysis (Model 2)
- 1.6.2.1 Approach 2: Volume Price Analysis
- 1.7 List Of Secondary Sources
- 1.8 List Of Primary Sources
- 1.9 List Of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 Pelvic Floor Electric Stimulator Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 List Of Key End Users
- 3.4 Market Dynamics
- 3.4.1 Market Driver Analysis
- 3.4.1.1 Increase In The Prevalence Of Urinary Incontinence
- 3.4.1.2 Increasing Awareness Initiatives
- 3.4.1.3 Rise In Geriatric Population
- 3.4.2 Market Restraints Analysis
- 3.4.2.1 Availability Of Alternatives
- 3.5 Pelvic Floor Electric Stimulator: Market Analysis Tools
- 3.5.1 Industry Analysis - Porter's
- 3.5.2 Pestle Analysis
- 3.5.3 Major Deals And Strategic Alliances
- 3.5.3.1 New Product Launch
- 3.5.3.2 Acquisition
- 3.5.3.3 Partnerships
- 3.5.4 Market Entry Strategies
Chapter 4 Pelvic Floor Electric Stimulator Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 4.1 Definition And Scope
- 4.2 Application Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Global Pelvic Floor Electric Stimulator Market, By Application, 2018 To 2030
- 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 4.5.1 Urinary Incontinence
- 4.5.1.1 Urinary Incontinence Market, 2018 - 2030 (USD Million)
- 4.5.2 Neurodegenerative Disorders
- 4.5.2.1 Neurodegenerative Disorders Market, 2018 - 2030 (USD Million)
- 4.5.3 Sexual Dysfunction
- 4.5.3.1 Sexual Dysfunction Market, 2018 - 2030 (USD Million)
Chapter 5 Pelvic Floor Electric Stimulator Market: Regional Market Analysis, Application, 2018 - 2030 (USD Million)
- 5.1 Definition & Scope
- 5.2 Regional Market Share Analysis, 2022 & 2030
- 5.3 Regional Market Dashboard
- 5.4 Regional Market Snapshot
- 5.5 Market Size, & Forecasts, And Trend Analysis, 2022 & 2030
- 5.6 North America
- 5.5.1 North America Market Estimates And Forecast, By Country, 2018 - 2030 (USD Million)
- 5.5.2 North America Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
- 5.5.3 North America Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
- 5.5.4 U.S.
- 5.5.4.1 Key Country Dynamics
- 5.5.4.2 Regulatory Structure & Reimbursement Framework
- 5.5.4.3 Competitive Scenario
- 5.5.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.5.5 Canada
- 5.5.5.1 Key Country Dynamics
- 5.5.5.2 Regulatory Structure & Reimbursement Framework
- 5.5.5.3 Competitive Scenario
- 5.5.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7 Europe
- 5.7.1 Europe Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
- 5.7.2 Europe Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
- 5.7.3 Europe Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
- 5.7.4 Uk
- 5.7.4.1 Key Country Dynamics
- 5.7.4.2 Regulatory Structure & Reimbursement Framework
- 5.7.4.3 Competitive Scenario
- 5.7.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.5 Germany
- 5.7.5.1 Key Country Dynamics
- 5.7.5.2 Regulatory Structure & Reimbursement Framework
- 5.7.5.3 Competitive Scenario
- 5.7.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.6 France
- 5.7.6.1 Key Country Dynamics
- 5.7.6.2 Regulatory Structure & Reimbursement Framework
- 5.7.6.3 Competitive Scenario
- 5.7.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.7 Italy
- 5.7.7.1 Key Country Dynamics
- 5.7.7.2 Regulatory Structure & Reimbursement Framework
- 5.7.7.3 Competitive Scenario
- 5.7.7.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.8 Spain
- 5.7.8.1 Key Country Dynamics
- 5.7.8.2 Regulatory Structure & Reimbursement Framework
- 5.7.8.3 Competitive Scenario
- 5.7.8.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.9 Denmark
- 5.7.9.1 Key Country Dynamics
- 5.7.9.2 Regulatory Structure & Reimbursement Framework
- 5.7.9.3 Competitive Scenario
- 5.7.9.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.10 Sweden
- 5.7.10.1 Key Country Dynamics
- 5.7.10.2 Regulatory Structure & Reimbursement Framework
- 5.7.10.3 Competitive Scenario
- 5.7.10.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.7.11 Norway
- 5.7.11.1 Key Country Dynamics
- 5.7.11.2 Regulatory Structure & Reimbursement Framework
- 5.7.11.3 Competitive Scenario
- 5.7.11.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.8 Asia Pacific
- 5.8.1 Asia Pacific Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
- 5.8.2 Asia Pacific Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
- 5.8.3 Asia Pacific Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
- 5.8.4 Japan
- 5.8.4.1 Key Country Dynamics
- 5.8.4.2 Regulatory Structure & Reimbursement Framework
- 5.8.4.3 Competitive Scenario
- 5.8.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.8.5 China
- 5.8.5.1 Key Country Dynamics
- 5.8.5.2 Regulatory Structure & Reimbursement Framework
- 5.8.5.3 Competitive Scenario
- 5.8.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.8.6 India
- 5.8.6.1 Key Country Dynamics
- 5.8.6.2 Regulatory Structure & Reimbursement Framework
- 5.8.6.3 Competitive Scenario
- 5.8.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.8.7 Australia
- 5.8.7.1 Key Country Dynamics
- 5.8.7.2 Regulatory Structure & Reimbursement Framework
- 5.8.7.3 Competitive Scenario
- 5.8.7.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.8.8 South Korea
- 5.8.8.1 Key Country Dynamics
- 5.8.8.2 Regulatory Structure & Reimbursement Framework
- 5.8.8.3 Competitive Scenario
- 5.7.8.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.8.9 Thailand
- 5.8.9.1 Key Country Dynamics
- 5.8.9.2 Regulatory Structure & Reimbursement Framework
- 5.8.9.3 Competitive Scenario
- 5.8.9.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.9 Latin America
- 5.9.1 Latin America Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
- 5.9.2 Latin America Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
- 5.9.3 Latin America Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
- 5.9.4 Brazil
- 5.9.4.1 Key Country Dynamics
- 5.9.4.2 Regulatory Structure & Reimbursement Framework
- 5.9.4.3 Competitive Scenario
- 5.9.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.9.5 Mexico
- 5.9.5.1 Key Country Dynamics
- 5.9.5.2 Regulatory Structure & Reimbursement Framework
- 5.9.5.3 Competitive Scenario
- 5.9.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.9.6 Argentina
- 5.9.6.1 Key Country Dynamics
- 5.9.6.2 Regulatory Structure & Reimbursement Framework
- 5.9.6.3 Competitive Scenario
- 5.9.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.10 MEA
- 5.10.1 MEA Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
- 5.10.2 MEA Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
- 5.10.3 MEA Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
- 5.10.4 South Africa
- 5.10.4.1 Key Country Dynamics
- 5.10.4.2 Regulatory Structure & Reimbursement Framework
- 5.10.4.3 Competitive Scenario
- 5.10.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.10.5 Saudi Arabia
- 5.10.5.1 Key Country Dynamics
- 5.10.5.2 Regulatory Structure & Reimbursement Framework
- 5.10.5.3 Competitive Scenario
- 5.10.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.10.6 UAE
- 5.10.6.1 Key Country Dynamics
- 5.10.6.2 Regulatory Structure & Reimbursement Framework
- 5.10.6.3 Competitive Scenario
- 5.10.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
- 5.10.7 Kuwait
- 5.10.7.1 Key Country Dynamics
- 5.10.7.2 Regulatory Structure & Reimbursement Framework
- 5.10.7.3 Competitive Scenario
- 5.10.7.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
Chapter 6 Pelvic Floor Electric Stimulator Market - Competitive Analysis
- 6.1 Recent Developments & Impact Analysis, By Key Market Participants
- 6.2 Private Companies
- 6.2.1 Regional Network Map
- 6.2.2 Company Market Position Analysis
- 6.3 Company Profiles
- 6.3.1 Zynex Medical Inc.
- 6.3.1.1 Company Overview
- 6.3.1.2 Financial Performance
- 6.3.1.3 Product Benchmarking
- 6.3.1.4 Strategic Initiatives
- 6.3.2 Tenscare, Ltd.
- 6.3.2.1 Company Overview
- 6.3.2.2 Product Benchmarking
- 6.3.3 Verity Medical Ltd
- 6.3.3.1 Company Overview
- 6.3.3.2 Product Benchmarking
- 6.3.4 Incontrol Medical
- 6.3.4.1 Company Overview
- 6.3.4.2 Product Benchmarking
- 6.3.4.3 Strategic Intiatives
- 6.3.5 The Prometheus Group
- 6.3.5.1 Company Overview
- 6.3.5.2 Product Benchmarking
- 6.3.5.3 Strategic Intiatives
- 6.3.6 Laborie, Inc.
- 6.3.6.1 Company Overview
- 6.3.6.2 Product Benchmarking
- 6.3.6.3 Strategic Intiatives
- 6.3.7 Activlife Technologies Pty Ltd.
- 6.3.7.1 Company Overview
- 6.3.7.2 Product Benchmarking
- 6.3.7.3 Strategic Intiatives
- 6.3.8 Athena Feminine Technologies, Inc.
- 6.3.8.1 Company Overview
- 6.3.8.2 Product Benchmarking
- 6.3.8.3 Strategic Intiatives
- 6.3.9 Atlantic Therapeutics
- 6.3.9.1 Company Overview
- 6.3.9.2 Product Benchmarking
- 6.3.9.3 Strategic Intiatives
- 6.3.10 Renovia Inc.
- 6.3.10.1 Company Overview
- 6.3.10.2 Product Benchmarking
- 6.3.10.3 Strategic Intiatives